Category: Finance
-
Diabetes Biotech Acquires GSK Spin-Off
24 September 2015. Intarcia Therapeutics, a developer of long-acting treatments for diabetes, is purchasing Phoundry Pharmaceuticals, a discoverer of engineered peptides for metabolic and other disorders. Phoundry — a spin-off company from GlaxoSmithKline in Research Triangle Park, North Carolina — is being acquired by Intarcia for an undisclosed amount of cash and stock. Intarcia, based…
-
Regeneron to Develop Antibody Therapy for Ebola
21 September 2015. Regeneron Pharmaceuticals Inc. received a contract from the U.S. Department of Health and Human Services to develop an engineered antibody designed to treat Ebola infections. The initial $17 million contract from HHS’s Biomedical Advanced Research and Development Authority or BARDA covers initial development and testing work on the therapy, but the program…
-
NIH Backing Alzheimer’s Onset Drug Trial
15 September 2015. National Institute on Aging, part of National Institutes of Health, is funding a late-stage clinical trial testing a current epilepsy drug as a treatment to delay the early onset of Alzheimer’s symptoms. The $7.5 million grant, part of NIH’s national plan to address Alzheimer’s disease, supports the trial testing a low-dose formulation…
-
Challenge Seeks Simple Medical Waste Incinerator
4 September 2015. A new challenge on InnoCentive is asking the public for a design of an efficient yet simple incinerator of medical waste generated during humanitarian emergencies. The competition has a total potential payout of $30,000 and a deadline for submissions of 4 November 2015. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowdsourcing competitions for…
-
Genome Editing Biotech Gains $70M in Venture Funds
1 September 2015. Intellia Therapeutics, a developer of therapies that edit human genomes to fix inherited disorders, raised $70 million in its second round of venture financing. OrbiMed HealthCare Fund Management led the funding round for the Cambridge, Massachusetts enterprise, with new and current investors taking part. Intellia Therapeutics, founded in November 2014, is a…
-
Grant Funds Research on Nanotech Cancer Treatments
1 September 2015. National Cancer Institute is renewing its support for a Northwestern University research center advancing nanotechnology to design new cancer treatments. The Northwestern University Center for Cancer Nanotechnology Excellence is the recipient of a new five-year, $11.7 million grant from National Cancer Institute, part of National Institutes of Health. The Center for Cancer…
-
Small Business Grant Funds Preclinical Lupus Research
24 August 2015. A grant from National Institute of Allergy and Infectious Diseases is funding preclinical research by a biotechnology company on stem cells as a therapy for a type of lupus. The $225,000 grant from NIAID, part of National Institutes of Health, is made to Ocata Therapeutics Inc. of Marlborough, Massachusetts under the institute’s…
-
Synthetic Biology Company Raises $200 Million in IPO
21 August 2015. Intrexon Corp., a company developing genomic solutions with synthetic biology, raised some $200 million in its initial public stock offering. The Germantown, Maryland enterprise issued 4,878,049 shares of common stock priced at $41.00, and traded on the New York Stock Exchange under the symbol XON. The company’s shares closed today at $45.46,…
-
Biomedical Accelerator Accepts 12 New Research Projects (Updated)
20 August 2015, Updated 21 August 2015 (see below). The Blavatnik Biomedical Accelerator at Harvard University is adding 12 new campus research projects to transform their findings into marketable products and services. The accelerator aims to bridge the gap between academic labs and venture financing, often called the Valley of Death because of the lack…
-
NSF Funds Math Tutoring Software Commercialization
18 August 2015. Software to help primary and secondary school students learn mathematics is receiving financial support from National Science Foundation to bring the software to market. NSF awarded a grant of nearly $200,000 to Beverly Woolf, a computer scientist at University of Massachusetts in Amherst, for the 18-month project. Woolf is developer of the…